These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. Chou KR; Chen R; Lee JF; Ku CH; Lu RB Int J Nurs Stud; 2004 Mar; 41(3):321-30. PubMed ID: 14967189 [TBL] [Abstract][Full Text] [Related]
4. The use of videos to inform smokers about different nicotine replacement products. May S; West R; Hajek P; Nilsson F; Foulds J; Meadow A Patient Educ Couns; 2003 Oct; 51(2):143-7. PubMed ID: 14572943 [TBL] [Abstract][Full Text] [Related]
5. Clinical inquiries. What is the most effective nicotine replacement therapy? Diefenbacher LJ; Smith PO; Nashelsky J; Lindbloom E J Fam Pract; 2003 Jun; 52(6):492-4. PubMed ID: 12791233 [No Abstract] [Full Text] [Related]
6. Reactivity to nicotine cues over repeated cue reactivity sessions. LaRowe SD; Saladin ME; Carpenter MJ; Upadhyaya HP Addict Behav; 2007 Dec; 32(12):2888-99. PubMed ID: 17537583 [TBL] [Abstract][Full Text] [Related]
8. Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch. Richmond RL; Kehoe L; de Almeida Neto AC Heart; 1997 Dec; 78(6):617-8. PubMed ID: 9470884 [TBL] [Abstract][Full Text] [Related]
10. Effect of 21 mg transdermal nicotine patches and smoking cessation on heart rate variability. Stein PK; Rottman JN; Kleiger RE Am J Cardiol; 1996 Apr; 77(9):701-5. PubMed ID: 8651120 [TBL] [Abstract][Full Text] [Related]
11. [Smoking cessation program using nicotine patch among physicians and pharmacists of Catalonia: results after 3-12 months]. Pardell H; Salto E; Ciruela J; Tresserras R; Gascon P; Salleras L An Med Interna; 1996 Jan; 13(1):16-20. PubMed ID: 8679817 [TBL] [Abstract][Full Text] [Related]
12. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Meine TJ; Patel MR; Washam JB; Pappas PA; Jollis JG Am J Cardiol; 2005 Apr; 95(8):976-8. PubMed ID: 15820167 [TBL] [Abstract][Full Text] [Related]
13. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. Le Houezec J Int J Tuberc Lung Dis; 2003 Sep; 7(9):811-9. PubMed ID: 12971663 [TBL] [Abstract][Full Text] [Related]
14. Adherence to nicotine replacement patch therapy in cardiovascular patients. Wiggers LC; Smets EM; Oort FJ; Storm-Versloot MN; Vermeulen H; van Loenen LB; Peters RJ; de Haes HC; Legemate DA Int J Behav Med; 2006; 13(1):79-88. PubMed ID: 16503844 [TBL] [Abstract][Full Text] [Related]
15. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers. Perkins KA; Lerman C; Keenan J; Fonte C; Coddington S Nicotine Tob Res; 2004 Jun; 6(3):501-7. PubMed ID: 15203784 [TBL] [Abstract][Full Text] [Related]
16. Naltrexone and nicotine patch smoking cessation: a preliminary study. Krishnan-Sarin S; Meandzija B; O'Malley S Nicotine Tob Res; 2003 Dec; 5(6):851-7. PubMed ID: 14750508 [TBL] [Abstract][Full Text] [Related]
17. Sleep effects of a 24-h versus a 16-h nicotine patch: a polysomnographic study during smoking cessation. Staner L; Luthringer R; Dupont C; Aubin HJ; Lagrue G Sleep Med; 2006 Mar; 7(2):147-54. PubMed ID: 16458598 [TBL] [Abstract][Full Text] [Related]
18. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments. Rose JE; Behm FM Nicotine Tob Res; 2004 Jun; 6(3):523-32. PubMed ID: 15203786 [TBL] [Abstract][Full Text] [Related]